Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Lithium
43.86
0.71%
Gold
2,663.70
(0.15%)
Copper
4.30
1.5%
Oil
72.20
0.46%
Bitcoin
75,359.52
(0.36%)
FTSE 100
8,166.70
(0.07%)
Nikkei 225
39,321.87
(1.07%)
Dow Jones
43,729.93
2.05%
Iron Ore
105.45
1.45%
USD/AUD
0.66
0.66%
Hang Seng
20,704.11
1.56%
Rhythm Biosciences (ASX: $RHY) secures $3.23 million in R&D funds
- Author: Stock Piper
Rhythm Biosciences receives significant R&D funding
Rhythm Biosciences (ASX:RHY), an Australian leader in predictive cancer diagnostics, has obtained $3.23 million from the Australian Government's Research & Development Tax Incentive program. This funding will support the commercialization of their second-generation ColoSTAT® product and aid in repaying a $1.15 million loan.
Rhythm Biosciences' strategic financial and operational outlook
Rhythm Biosciences has successfully secured $3.23 million from the Australian Government's R&D Tax Incentive program, which includes funds for fiscal years 2023 and 2024. These funds are earmarked to support ongoing operational activities, specifically the commercialization of the ColoSTAT® product, and to repay a $1.15 million loan. The company remains focused on its mission to provide accessible cancer diagnostics and plans to continue leveraging the R&D tax incentive program by filing a claim for the 2025 financial year. Rhythm Biosciences is strategically positioned to further its innovation and market reach, with a commitment to improving global cancer outcomes.
Executive insights on Rhythm Biosciences' progress
The receipt of these R&D funds is crucial in supporting our operational activities and financial strategy. We are committed to delivering our simple, affordable cancer diagnostics to improve patient outcomes globally.
RHYTHM BIOSCIENCES LIMITED
RHY | ASX | Health Care
0.1050(+0%)
At close 06/11 (AEDT)
Market cap
$26.1M
Volume
237,272
DY Yield
PE Ratio
52 Week Range
0.042 - 0.23
1YR Return
N / A
Please login to comment
0 Comments
ASX News, First
& Fast.
By clicking Subscribe, you agree to our Terms & Conditions
ASX News, First And Fast.
By clicking Subscribe, you agree to our Terms & Conditions
© 2024 Stock Piper.
All rights reserved
All rights reserved
Support
© 2024 Stock Piper. All rights reserved
Social Media Auto Publish Powered By : XYZScripts.com
Stock Piper AI Index Coming Soon!
Join our Newsletter to gain exclusive insight and be notified once we are live.
By clicking Subscribe, you agree to our Terms & Conditions
ASX News, First And Fast.
Get all the latest market updates straight to your inbox.
By clicking Subscribe, you agree to our Terms & Conditions